Toon 1 - 11 resultaten van 11 Voor zoekopdracht '"serologic data"', zoektijd: 0,02s Verfijn jouw resultaten
  1. 1
    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.

    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.

    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.

    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..

    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.

    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. door Bethel Alebel Bayrau (22676588)

    Gepubliceerd in 2025
    Onderwerpen:
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: